IRADIMED CORP — Director's Dealing 2025

Dec 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2025-12-11

Reporting Person: Chiprin Jeff (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-11	Common Stock	M	996	—	Acquired	996	Direct
2025-12-11	Common Stock	F	309	$97.38	Disposed	687	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-11	Restricted Stock Units	$	M	996	Disposed		Common Stock (996)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.